• Home
  • NEW DAY MEDICINE
  • 5 (67) 2024
  • 14 -5 (67) 2024 - Nuriddinova N.F., Kurbonova Z.Ch. - LABORATORY DIAGNOSTICS OF HEMOSTASIS INDICATORS ON THE BACKGROUND OF ANTIVIRUS THERAPY IN HCV ETIOLOGY OF LIVER CIRRHOSIS

14 -5 (67) 2024 - Nuriddinova N.F., Kurbonova Z.Ch. - LABORATORY DIAGNOSTICS OF HEMOSTASIS INDICATORS ON THE BACKGROUND OF ANTIVIRUS THERAPY IN HCV ETIOLOGY OF LIVER CIRRHOSIS

LABORATORY DIAGNOSTICS OF HEMOSTASIS INDICATORS ON THE BACKGROUND OF ANTIVIRUS THERAPY IN HCV ETIOLOGY OF LIVER CIRRHOSIS

Nuriddinova N.F. Tashkent Medical Academy

Kurbonova Z.Ch. Tashkent Medical Academy

Zaynutdinova D.L. Tashkent Medical Academy

Resume

According to WHO data, there are approximately 325 million people in the world. A person is infected with parenteral hepatitis viruses, 500 mln. more people than In 2015, 1.34 million deaths were observed due to viral hepatitis. The physiology of the hemostasis system is directly related to the activity of the liver, because hepatocytes produce many coagulation factors, anticoagulant proteins, components of the fibrinolysis system, and factors that stimulate thrombopoiesis. Complications such as bleeding from esophageal varices, hematomas, hemorrhagic purpura, bleeding from the nose and gums, and menorrhagia in patients with chronic diffuse liver diseases remain an urgent clinical problem. Purpose: to evaluate laboratory diagnostics of hemostasis indicators against the background of antiviral therapy in liver cirrhosis with HCV etiology. Data were collected from patients treated with cirrhosis of the liver of HCV etiology in the departments of hematology and hepatobiliary pathology of the 1st clinic of the Tashkent Medical Academy in 2020-2023.

Keywords: liver cirrhosis, hepatitis, fibrinogen, platelet, bleeding.

First page

78

Last page

84

For citation: Nuriddinova N.F., Kurbonova Z.Ch., Zaynutdinova D.L. - LABORATORY DIAGNOSTICS OF HEMOSTASIS INDICATORS ON THE BACKGROUND OF ANTIVIRUS THERAPY IN HCV ETIOLOGY OF LIVER CIRRHOSIS//New Day in Medicine 5(67)2024 78-84 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Bulatova I.A. Functional state of the endothelium and its diagnostic significance in assessing the severity of chronic diffuse liver diseases: abstract of thesis. // Candidate of Medical Sciences. – Ekaterinburg, 2009;17.
  2. Bilalova A.R. Features of the clinic and hemostasis system in patients with chronic hepatitis and cirrhosis of the liver: abstract of thesis. // Candidate of Medical Sciences - Moscow, 2015;24.
  3. Kurbonova Z.Ch. Features of hemostatic system disorders in patients with chronic hepatitis and liver cirrhosis of viral etiology 14.00.29-Hematology and transfusiology. / Author's abstract. dis. ...cand. honey. Sci. Tashkent – 2019; 45 p.
  4. Pavlov Ch.S., Shulpekova Yu.O., Zolotarevsky V.B., Kogan E.A., Ivashkin V.T. Modern methods for early diagnosis of liver fibrosis // Clinical Medicine. 2005;12:58-60.
  5. Serov V.V., Bushueva N.V., Ignatova T.M., Aprosina Z.G. Viral and host factors in the development and progression of chronic viral hepatitis C and B // Russian Journal of Gastroenterology, Hepatology and Coloproctology. 2006;4:12–23.
  6. Ustinova M.N. Platelet aggregation in patients with chronic diffuse liver diseases and its correction by intravenous ozone therapy: abstract of thesis. // Can. of Medical Sciences. – Moscow, 2005;25.
  7. Al Ghumlas A.K., Abdel Gader A.G., Al Faleh F.Z. Haemostatic abnormalities in liver disease: could some haemostatic tests be useful as liver function tests? // Blood Coagul Fibrinolysis.–2005;16(5):329-335.
  8. Babadjanova, S.A., Islamova, Z.S., Kurbanova, Z.Ch., Yusufkhojaeva, K.S., Inoyatova, F.Kh. Disturbance of coagulative hemostasis among patients with henoch-schonlein purpura // Indian Journal of Forensic Medicine and toxicology, 2020; 14(4):7438-7442.
  9. Babadjanova Sh.A., Zaynutdinova D.L. Frequency and characteristics of immune thrombocytopenia at different stages of pregnancy // Nazariy va klinik tibbiyot jurnali. 2021;5:9-12. ISSN 2091-5853
  10. Batirova A.S., Bakanov M.I., Surkov A.N. The modern concepts of hemostasis system under Chronic diseases of liver: the publication review // Klin.Lab.Diagn. 2015;60(8):40-44.
  11. Bienholz A., Canbay A., Saner F.H. Coagulation management in patients with liver disease // Med.Klin.Intensivmed Notfmed. 2016;111(3):224-234.
  12. Caldwell S.H., Hoffman M., Lisman T.et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management // Hepatology. 2006;44:44.
  13. Francoz C., Belghiti J., Vilgrain V. et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation // Gut. 2005;54(5):691-697.
  14. Hartmann M., Cynthia S., Fuat H. Hemostasis in liver transplantation: Pathophysiology, monitoring, and treatment // World Journal of Gastroenterology. 2016;22(4):1541–1550.
  15. Hollestelle M.J., Geertzen H.G.M., Straatsburg I.H., van Gulik T.M., van Mourik J.A. Factor VIII expression in liver disease // Thromb Haemost. 2004;91:267–275.
  16. Huard G., Bilodeau M. Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: A systematic review // Int.J.Hepatol. 2012;6–7.
  17. Iancu R.I., Iancu D., Murărescu D., Nechifor M., Costuleanu M. Platelet functions in acute and chronic experimentally induced hepatopathia // Rev.Med.Chir.Soc.Med.Nat.Iasi. 2010;114(4):1101–1106.
  18. Kurbonova Z.C., Babadjanova S.A., Islamova Z.S., Musayeva N.B., Babadjanov A.S.(2020). Some features of hemorrhagic syndrome in chronic diffuse liver diseases. // Indian Journal of Forensic Medicine and Toxicology, 2020;14(4):7443-7448.
  19. Kurokawa T., Ohkohchi N. Platelets in liver disease, cancer and regeneration // World J.Gastroenterol. 2017;.23(18):3228–3239.
  20. Northup P.G., Fallon M.B., Sundaram V. Hypercoagulation and thrombophilia in liver disease // J.Thromb.Haemost.–2008.–Vol.6,–P.2–9.

    file

    download